Articles

This article presents a strategic update on Israeli patent law and practice, including filing procedures, prosecution pathways, examination trends and enforcement. It discusses recent Israeli Patent Office (ILPO) practice developments, proposed legislative reforms and key issues in biotech, AI and PTE eligibility. With a focus on practical implications for global applicants, this article also addresses […]

Intellectual property is one of the most significant assets of innovation-driven companies – especially in times of political, economic, and security uncertainty. Israel’s current economic and security realities directly affect the pace of innovation and the ways entrepreneurs and companies choose to protect their inventions and brands. Last week, the Israel Patent Office published its […]

Background: In an interesting decision handed down by the Haifa Magistrates Court,[1] Justice Tali Merom expressed a clear-cut position against providing a court-appointed expert with a medical summary prepared using artificial intelligence. The plaintiff, a woman injured in three traffic accidents, filed a compensation claim. The Court appointed an expert and instructed the parties to […]

According to Start-Up Nation Central (SNC), AI represents about 30% of Israel’s start-ups and attracts nearly half of total company funding.

Adv. and Patent Attorney Ehud Hausman, Head of the Hitech Practice, sheds light on patent protection policies in companies integrating generative AI technologies into their products and where Israel stands in comparison to the rest of the world.

Will a flawed R&D agreement for developing innovative herbicides jeopardize the success of a subsequent patent application? In the Bionome matter, the court in England was called upon to resolve a dispute between parties who engaged in a joint research and development project and later disagreed over patent ownership. Dr. John Russell Clearwater invented an […]

Further to the previous report in respect of the case of Diana Zohar v. Meta and adidas1,2, the Supreme Court recently rejected the appeal filed by Diana Zohar and upheld the ruling of the Tel Aviv District Court, which determined that Zohar employed sophisticated methods to conceal the sale of counterfeit goods, including using hidden […]

In an article for “The Marker” newspaper, Dima explains how patents can serve as a source of technological and business intelligence. He highlights how integrating patents with additional data sources can provide strategic insights and help identify opportunities.

Recognition of a Biological Substance as a “New Substance” Despite the Absence of Differences in the Primary and Secondary Structure of the Protein Compared to a Previously Registered Substance. For example, in the matter of Bayer,[8] a request for PTE was denied based on the finding that the amino acid sequence of the API in Kovaltry® […]